Login
Navigate Fool.com
Will SCR beat
the market?
Community Rating: 2 Stars: Unattractive

0.00 0.00 (0.00%)

Quote as of

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open 0.00
Previous Close 0.00
Daily Range 0.00 - 0.00
52-Week Range 0.00 - 0.00
Market Cap 0.0000
P/E Ratio 56.47
Dividend (Yield) 0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS 0.35

How do you think SCR
will perform against the market?

Top SCR Bull/Bear Pitches

 

mrindependent (< 20)
Submitted August 25, 2009

Simcere Pharmaceutical is a rapidly growing generic pharmaceuticals company located in China. The company has tripled its revenues in the last 5 years and seems poised for future growth. Price has … More

0 Replies Reply Report this Post
 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

Are Simcere Pharmaceutical Group's Earnings Worse Than They Look?

Don't just count the cash, time it.

Sector Update: Healthcare Shares Mixed Pre-Market; Astex Soars 10% on Topline Results from Study of

Sector Update: Healthcare Shares Mixed Pre-Market; Astex Soars 10% on Topline Results from Study of SGI-110

Sector Update: Healthcare

China's Simcere to be taken private by Chairman for $495 mln

Asian Shares Rise, Led by Japan

Bristol-Myers, Simcere to Bring Rheumatoid Arthritis Drug to China

Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and Co-Commercialize Orencia® SC (a

Simcere Pharmaceutical Group. Passes This Key Test

Look here for a clue.

Some Numbers at Simcere Pharmaceutical Group. that Make Your Stock Look Good

Look here for a clue.

Here's 1 Reason Simcere Pharmaceutical Group. Looks Weak

Keep your eye on margins.

See More SCR News...

Sector

Healthcare

Industry

Drugs

Simcere Pharmaceutical Group (SCR) Description

The Company is a manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market. Website: http://www.simcere.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks